Replies to post #243242 on Biotech Values

[DewDiligence]

ABUS/ASMB—As a consequence of #msg-169454462, the phase-2 HBV trial testing the combination of ABUS’ AB-729 and ASMB’s VBR has been terminated, except for the gathering od safety data:

https://finance.yahoo.com/news/arbutus-biopharma-provides-phase-2a-201000581.html